Hims & Hers Health, Inc. (HIMS)
31.38
+0.15
(+0.48%)
USD |
NYSE |
Jan 16, 16:00
30.18
-1.20
(-3.82%)
Pre-Market: 09:06
Hims & Hers Health EPS Diluted (Quarterly): 0.0634 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.211 |
| Pfizer Inc. | 0.6197 |
| Boston Scientific Corp. | 0.5048 |
| Teladoc Health, Inc. | -0.2798 |
| Recursion Pharmaceuticals, Inc. | -0.363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 15.77M |
| Revenue (Quarterly) | 598.98M |
| Total Expenses (Quarterly) | 583.20M |
| Enterprise Value | 7.632B |
| Gross Profit Margin (Quarterly) | 60.97% |
| Profit Margin (Quarterly) | 2.63% |
| Earnings Yield | 1.72% |
| Operating Earnings Yield | 1.69% |
| Normalized Earnings Yield | 1.942 |